BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 22800507)

  • 1. 3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells.
    Beaver LM; Yu TW; Sokolowski EI; Williams DE; Dashwood RH; Ho E
    Toxicol Appl Pharmacol; 2012 Sep; 263(3):345-51. PubMed ID: 22800507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broccoli-derived phytochemicals indole-3-carbinol and 3,3'-diindolylmethane exerts concentration-dependent pleiotropic effects on prostate cancer cells: comparison with other cancer preventive phytochemicals.
    Wang TT; Schoene NW; Milner JA; Kim YS
    Mol Carcinog; 2012 Mar; 51(3):244-56. PubMed ID: 21520295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural indoles, indole-3-carbinol and 3,3'-diindolymethane, inhibit T cell activation by staphylococcal enterotoxin B through epigenetic regulation involving HDAC expression.
    Busbee PB; Nagarkatti M; Nagarkatti PS
    Toxicol Appl Pharmacol; 2014 Jan; 274(1):7-16. PubMed ID: 24200994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells.
    Clarke JD; Hsu A; Yu Z; Dashwood RH; Ho E
    Mol Nutr Food Res; 2011 Jul; 55(7):999-1009. PubMed ID: 21374800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemopreventive agent 3,3'-diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases.
    Li Y; Li X; Guo B
    Cancer Res; 2010 Jan; 70(2):646-54. PubMed ID: 20068155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
    Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
    Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer.
    Garikapaty VP; Ashok BT; Tadi K; Mittelman A; Tiwari RK
    Biochem Biophys Res Commun; 2006 Feb; 340(2):718-25. PubMed ID: 16380095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
    Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
    Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle-dependent effects of 3,3'-diindolylmethane on proliferation and apoptosis of prostate cancer cells.
    Chinnakannu K; Chen D; Li Y; Wang Z; Dou QP; Reddy GP; Sarkar FH
    J Cell Physiol; 2009 Apr; 219(1):94-9. PubMed ID: 19062173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer.
    Singh-Gupta V; Banerjee S; Yunker CK; Rakowski JT; Joiner MC; Konski AA; Sarkar FH; Hillman GG
    Cancer Lett; 2012 May; 318(1):86-92. PubMed ID: 22155105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines.
    Jang YG; Hwang KA; Choi KC
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells.
    Hsu JC; Zhang J; Dev A; Wing A; Bjeldanes LF; Firestone GL
    Carcinogenesis; 2005 Nov; 26(11):1896-904. PubMed ID: 15958518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells.
    Le HT; Schaldach CM; Firestone GL; Bjeldanes LF
    J Biol Chem; 2003 Jun; 278(23):21136-45. PubMed ID: 12665522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic dimer of indole-3-carbinol: second generation diet derived anti-cancer agent in hormone sensitive prostate cancer.
    Garikapaty VP; Ashok BT; Tadi K; Mittelman A; Tiwari RK
    Prostate; 2006 Apr; 66(5):453-62. PubMed ID: 16353249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258.
    Vallo S; Mani J; Stastny M; Makarević J; Juengel E; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
    Invest New Drugs; 2013 Apr; 31(2):265-72. PubMed ID: 22801803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat.
    Choi SY; Kee HJ; Jin L; Ryu Y; Sun S; Kim GR; Jeong MH
    Biomed Pharmacother; 2018 May; 101():145-154. PubMed ID: 29482060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,3'-Diindolylmethane and genistein decrease the adverse effects of estrogen in LNCaP and PC-3 prostate cancer cells.
    Smith S; Sepkovic D; Bradlow HL; Auborn KJ
    J Nutr; 2008 Dec; 138(12):2379-85. PubMed ID: 19022961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
    McLeod AB; Stice JP; Wardell SE; Alley HM; Chang CY; McDonnell DP
    Prostate; 2018 Mar; 78(4):266-277. PubMed ID: 29243324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ring-substituted analogs of 3,3'-diindolylmethane (DIM) induce apoptosis and necrosis in androgen-dependent and -independent prostate cancer cells.
    Goldberg AA; Titorenko VI; Beach A; Abdelbaqi K; Safe S; Sanderson JT
    Invest New Drugs; 2014 Feb; 32(1):25-36. PubMed ID: 23709189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indole-3-carbinol and 3',3'-diindolylmethane modulate androgen's effect on C-C chemokine ligand 2 and monocyte attraction to prostate cancer cells.
    Kim EK; Kim YS; Milner JA; Wang TT
    Cancer Prev Res (Phila); 2013 Jun; 6(6):519-29. PubMed ID: 23585426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.